Kipriyanov et al., 1995 - Google Patents
Bacterial expression and refolding of single-chain Fv fragments with C-terminal cysteinesKipriyanov et al., 1995
- Document ID
- 10152788126013001829
- Author
- Kipriyanov S
- Dübel S
- Breitling F
- Kontermann R
- Heymann S
- Little M
- Publication year
- Publication venue
- Cell biophysics
External Links
Snippet
Two antibody single-chain Fv (scFv) fragments carrying five C-terminal histidine residues were expressed in Escherichia coli as periplasmic inclusion bodies. Their variable heavy (VH) and light (VL) domains are derived from the mouse monoclonal antibody 215 …
- 108010070144 Single-Chain Antibodies 0 title abstract description 7
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2317/00—Immunoglobulins specific features
- C07K2317/60—Immunoglobulins specific features characterized by non-natural combinations of immunoglobulin fragments
- C07K2317/62—Immunoglobulins specific features characterized by non-natural combinations of immunoglobulin fragments comprising only variable region components
- C07K2317/622—Single chain antibody (scFv)
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
- C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
- C07K16/28—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants
- C07K16/30—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants from tumour cells
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
- C07K16/44—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material not provided for elsewhere, e.g. haptens, metals, DNA, RNA, amino acids
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
- C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
- C07K16/32—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against translation products of oncogenes
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2317/00—Immunoglobulins specific features
- C07K2317/20—Immunoglobulins specific features characterized by taxonomic origin
- C07K2317/21—Immunoglobulins specific features characterized by taxonomic origin from primates, e.g. man
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2317/00—Immunoglobulins specific features
- C07K2317/30—Immunoglobulins specific features characterized by aspects of specificity or valency
- C07K2317/34—Identification of a linear epitope shorter than 20 amino acid residues or of a conformational epitope defined by amino acid residues
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
- C07K16/06—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies from serum
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by the preceding groups
- G01N33/48—Investigating or analysing materials by specific methods not covered by the preceding groups biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
- C07K16/46—Hybrid immunoglobulins
- C07K16/468—Immunoglobulins having two or more different antigen binding sites, e.g. multifunctional antibodies
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
- C07K16/08—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from viruses
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2317/00—Immunoglobulins specific features
- C07K2317/50—Immunoglobulins specific features characterized by immunoglobulin fragments
- C07K2317/55—Fab or Fab'
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| Kipriyanov et al. | Recombinant single-chain Fv fragments carrying C-terminal cysteine residues: production of bivalent and biotinylated miniantibodies | |
| Kipriyanov et al. | Single-chain antibody streptavidin fusions: tetrameric bifunctional scFv-complexes with biotin binding activity and enhanced affinity to antigen | |
| Kipriyanov et al. | Affinity enhancement of a recombinant antibody: formation of complexes with multiple valency by a single-chain Fv fragment–core streptavidin fusion | |
| Müller et al. | The first constant domain (CH1 and CL) of an antibody used as heterodimerization domain for bispecific miniantibodies | |
| JP3474574B2 (en) | Recombinant disulfide stabilized polypeptide fragments with binding specificity | |
| Kipriyanov et al. | Bacterial expression and refolding of single-chain Fv fragments with C-terminal cysteines | |
| Dübel et al. | Bifunctional and multimeric complexes of streptavidin fused to single chain antibodies (scFv) | |
| Hudson et al. | High avidity scFv multimers; diabodies and triabodies | |
| Le Gall et al. | Di-, tri-and tetrameric single chain Fv antibody fragments against human CD19: effect of valency on cell binding | |
| Kortt et al. | Recombinant anti‐sialidase single‐chain variable fragment antibody: Characterization, formation of dimer and higher‐molecular‐mass multimers and the solution of the crystal structure of the single‐chain variable fragment/sialidase complex | |
| Inbar et al. | Localization of antibody-combining sites within the variable portions of heavy and light chains | |
| Mallender et al. | Construction, expression, and activity of a bivalent bispecific single-chain antibody. | |
| Alfthan et al. | Properties of a single-chain antibody containing different linker peptides | |
| Lu et al. | The effect of variable domain orientation and arrangement on the antigen-binding activity of a recombinant human bispecific diabody | |
| US6025165A (en) | Methods for producing multivalent antigen-binding proteins | |
| Reiter et al. | Disulfide stabilization of antibody Fv: computer predictions and experimental evaluation | |
| Better et al. | Potent anti-CD5 ricin A chain immunoconjugates from bacterially produced Fab'and F (ab') 2. | |
| Guo et al. | Construction and high-level expression of a single-chain Fv antibody fragment specific for acidic isoferritin in Escherichia coli | |
| Zuo et al. | An efficient route to the production of an IgG-like bispecific antibody | |
| Rosso et al. | Expression and functional characterization of a single chain Fv antibody directed against secretions involved in plant nematode infection process | |
| JP2000516452A (en) | Immunoglobulin superfamily domains and fragments with increased solubility | |
| RU2003133973A (en) | ANTI-HUMAN-OVARIAN-CARCINOMIC AND ANTI-HUMAN-ANTI-CD-3, SPECIFIC ANTIBODY | |
| Mousli et al. | A recombinant single-chain antibody fragment that neutralizes toxin II from the venom of the scorpion Androctonus australis hector | |
| DK2504359T3 (en) | Monospecifikke polypeptidreagenser | |
| Lu et al. | Fab-scFv fusion protein: an efficient approach to production of bispecific antibody fragments |